These results indicate that in IgG4-RD B cells, the interaction of USP25 with RAC1 is decreased, resulting in increased ubiquitination of RAC1, which reduces ALDOA release from the cytoskeleton and thus, also reduces glycolysis. Here, USP25 is linked to immunoglobulin G4-related sclerosing disease.